FRC
FRC Logo
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us

Resources

  • Videos
  • Research Reports
  • FAQ

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Research
Get Access
Sign In
Nexeon MedSystems Inc. Stock AnalysisComprehensive stock analysis for Nexeon MedSystems Inc. (NXNN) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisNXNN
NXNN
Nexeon MedSystems Inc.
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
NXNN
Home🔹Stocks🔹Nexeon MedSystems Inc.

Nexeon MedSystems Inc.

NXNN•OTC

Nexeon MedSystems Inc.

NXNN•OTC
Market cap
$78.63K
Sentiment

Your view on NXNN

Mkt Cap
$78.63K
Sentiment
Your view
NXNN
Nexeon MedSystems Inc.
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
NXNN
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Nexeon MedSystems Inc.

Industry
Medical - Devices
Sector
Healthcare
CEO
William Rosellini
Headquarters
1910 Pacific Avenue, Dallas, TX, US
Industry
Medical - Devices
Sector
Healthcare
CEO
William Rosellini
Headquarters
1910 Pacific Avenue, Dallas, TX, US
Description

Nexeon MedSystems Inc., a medical device company, develops, manufactures, and commercializes neurostimulation technology for the treatment of various neurological disorders through electrical stimulation of neural tissues. Its neurostimulation technology platform would provide treatment to patients in several neurostimulator markets, including deep brain stimulation, peripheral electrical nerve stimulation, sacral nerve stimulation, spinal cord stimulation, vagus nerve stimulation, and other neurostimulator markets. The company develops the Viant, a deep brain stimulation system for Parkinson's disease in the United States, as well as for Parkinson's disease, Essential Tremor, and Dystonia in Europe. Nexeon MedSystems Inc. was founded in 2015 and is based in Dallas, Texas.

Infographics

Visual summary of the business at a glance.

FRC Research

Media

Videos and interviews covering the company.

Financial Data

Stock Data

Price chart, volume, and trading data.

Fair Value

What FRC thinks the stock is worth vs. the current price.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

Financial Statements

Income statement, balance sheet, and cash flow statements.

Peer Comparison

Comparables

List of peer companies in the same industry.

Ownership & News

Institutional Ownership

Which funds and firms own the stock.

Insider Trading

Recent buying and selling by company executives.

Senate Trading

U.S. Senator disclosures filed under the STOCK Act.

News

Latest headlines and market coverage.

News

Latest Market News